STUDY OF THE NQO1 RS1800566 POLYMORPHISM AND ASCL1 GENE EXPRESSION IN PATIENTS WITH OCCUPATIONAL TRINITROTOLUENE POISONING

Hoang Hiep Nguyen1, , Van Bang Nguyen1, Tien Sang Trieu2, Van Khoa Tran2, Van Phong Nguyen2
1 Military Hospital 103
2 Department of Biology and Medical Genetics, Vietnam Military Medical University

Main Article Content

Abstract

Objectives: To investigate the rs1800566 polymorphism in the NQO1 gene and evaluate  ASCL1 gene expression levels in patients with occupational trinitrotoluene (TNT) poisoning. Methods: A case-control and descriptive study was conducted on 200 workers occupationally exposed to trinitrotoluene (TNT), including 100 patients with TNT poisoning and 100 non-poisoned controls from December 2023 to December 2025. The rs1800566 polymorphism of the NQO1 gene was determined using the PCR-RFLP technique, and ASCL1 gene expression levels were relatively quantified by qRT-PCR. Results: The frequencies of AA/AG/GG genotypes in the researched group were 15%, 46%, and 39%, respectively, compared to 25%, 53%, and 22% in the control group. The allele frequencies of A/G were 76/124 in the researched group and 103/97 in controls. The GG genotype was more prevalent in the researched group (p < 0.05). The GG genotype was associated with a higher risk of TNT poisoning compared to the AA genotype (OR = 2.95; p < 0.01), and the G allele was associated with a higher risk compared to the A allele (OR = 1.73; p < 0.01). ASCL1 gene expression levels were lower in the researched group than in the control group, with median values of 0.44 and 0.93, respectively (p < 0.001). Conclusion:The NQO1 rs1800566 polymorphism, particularly the GG genotype and G allele, is associated with an increased risk of occupational TNT poisoning. ASCL1 gene expression is significantly reduced in patients with TNT poisoning compared to the control group.

Article Details

References

1. Adomako-Bonsu AG, Jacobsen J and Maser E. Metabolic activation of 2,4,6-trinitrotoluene; a case for ROS-induced cell damage. Redox Biology. 2024; 72: 103082.
2. NQO1 NAD(P)H quinone dehydrogenase 1, NCBI, https://www.ncbi.nlm.nih.gov/ gene/1728.
3. Ross D, and Siegel D. The diverse functionality of NQO1 and its roles in redox control. Redox Biology. 2021; 41:101950.
4. Solta A, Ernhofer B, Boettiger K, et al. Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation. Cancer Metab. 2025; 13(1):16.
5. Bộ Y tế. Thông tư số 15/2016/TT-BYT "Quy định về bệnh nghề nghiệp được hưởng bảo hiểm xã hội”. 2016.
6. Agúndez JA, García-Martín E, Martínez C, et al. NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis. BMC Neurol. 2014; 14:87.
7. Fan Y, Hu D, Feng B, et al. The NQO1 C609T polymorphism and hepatocellular carcinoma risk. Tumor Biology. 2014; 35(8):7343-7350.
8. Peng Q, Lu Y, Lao X, et al. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: Evidence from an updated meta-analysis. Diagn Pathol. 2014; 9:100
9. Nebert DW, Roe AL, Vandale SE, et al. NAD(P)H: Quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review. Genetics in Medicine. 2002; 4(2):62-70.
10. Liu JT and Bain LJ. Arsenic inhibits hedgehog signaling during P19 cell differentiation. Toxicol Appl Pharmacol. 2014; 281(3):243-253.